BMCM
CL icon

Bryn Mawr Capital Management’s Colgate-Palmolive CL Stock Holding History

Bryn Mawr Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Sell
3,177
-623
-16% -$55.5K 0.01% 373
2025
Q4 		$300K Sell
3,800
-536
-12% -$42K 0.01% 354
2025
Q3 		$347K Buy
4,336
+14
+0.3% +$1.19K 0.02% 328
2025
Q2 		$393K Buy
4,322
+1,656
+62% +$151K 0.02% 299
2025
Q1 		$250K Sell
2,666
-17,767
-87% -$1.59M 0.02% 343
2024
Q4 		$1.86M Buy
20,433
+9,751
+91% +$930K 0.1% 162
2024
Q3 		$1.11M Sell
10,682
-15
-0.1% -$1.53K 0.06% 208
2024
Q2 		$1.04M Sell
10,697
-28,837
-73% -$2.66M 0.06% 212
2024
Q1 		$971K Buy
39,534
+30,795
+352% +$2.61M 0.06% 228
2023
Q4 		$697K Buy
8,739
+4,876
+126% +$367K 0.04% 247
2023
Q3 		$275K Buy
3,863
+96
+3% +$7.18K 0.02% 334
2023
Q2 		$290K Buy
+3,767
New +$292K 0.03% 246
2022
Q4 		– Sell
-3,843
Closed -$270K – 268
2022
Q3 		$270K Buy
3,843
+50
+1% +$3.92K 0.1% 120
2022
Q2 		$304K Sell
3,793
-9
-0.2% -$704 0.1% 118
2022
Q1 		$288K Buy
+3,802
New +$301K 0.08% 130

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bryn Mawr Capital Management's CL Position: Q1 2026 in Review

Bryn Mawr Capital Management reduced its Colgate-Palmolive (CL) stake by 16% in Q1 2026, selling an estimated $55.5K and leaving 3,177 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #373.

Bryn Mawr Capital Management first reported a position in CL in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.86M in Q4 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Bryn Mawr Capital Management held 3,177 shares of Colgate-Palmolive worth $271K as of Q1 2026.
  • Bryn Mawr Capital Management sold 623 Colgate-Palmolive shares in Q1 2026, an estimated $55.5K.
  • Colgate-Palmolive made up 0.01% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #373 holding.
  • Bryn Mawr Capital Management first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 15 quarters since.
  • Bryn Mawr Capital Management's Colgate-Palmolive position peaked at $1.86M in Q4 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.